Meyka Pro banner
CDT Equity Inc.

CDT Equity Inc. (CDT) Stock Overview

Explore CDT Equity Inc.’s financial performance, market position, analyst ratings, and future outlook.

CDT●NASDAQ
HealthcareBiotechnology
$0.40
$0.04(9.66%)
U.S. Market opens in 40h 26m

CDT Equity Inc. (CDT)

Meyka AI Score

Z

Key Financials

Market Cap181.9K
P/E Ratio-0.00
EPS (TTM)$-157.83
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.62
3 Months$1.03
1 Year Target$0.00

CDT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of CDT Equity Inc. (NASDAQ: CDT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, CDT Equity Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CDT on the NASDAQ shows an RSI of 46.24, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind CDT Equity Inc.'s NASDAQ-traded stock include a P/E ratio of -0.00 and a market capitalization of 181.9K. Combined with our AI analysis, these give both institutional and retail investors a clear view of CDT on the NASDAQ.

Price Performance (NASDAQ: CDT)

1-Day Change
-11.94%
5-Day Change
-71.72%
1-Month Change
-95.66%
3-Month Change
-99.98%
6-Month Change
-100.00%
Year-to-Date (YTD) Change
-100.00%
1-Year Change
-100.00%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

646 491 9132
4581 Tamiami Trail North, Naples, FL, 34103

Company Facts

40 Employees
IPO DateMar 28, 2022
CountryUS
Actively Trading

Frequently Asked Questions